Serina Therapeutics Inc, based in Huntsville, AL, is a pioneering biotechnology company that specializes in the development of programmable drug delivery systems. Their proprietary POZ platform technology allows for targeted and continuous delivery of small molecules, offering a safe and effective treatment option for various medical conditions. With a focus on the central nervous system, Serina Therapeutics is dedicated to addressing significant unmet needs in the field of CNS drug development.
Collaborating with partners, Serina Therapeutics also explores the potential of lipid nanoparticles (LNPs) for drug delivery in mRNA immunology, showcasing the versatility of their POZ platform technology. Additionally, their innovative approach enables improved efficacy against low-density targets in cancer treatment through the increased drug antibody ratio (DAR) of antibody-drugs. With a strong portfolio of patents and years of development experience, Serina Therapeutics is at the forefront of groundbreaking scientific advancements.
Generated from the website